Illumina has announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a coho...
Lucence is bringing its clinical genomics expertise to Singapore’s next phase of precision medicine, supporting a ...
The Asia Pacific One Health Initiative (APOHI) has been launched in Singapore to strengthen regional preparedness agains...
A new Singapore study found that around one in six (16.7%) higher-risk patients with hormone receptor-positive (HR+), HE...
Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral anti...
Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximat...
AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...
360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...
GCCL, a South Korea-based leading global clinical trial central laboratory, has signed a Memorandum of Understanding (Mo...
Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organisations, has announced the...
The Association for the Advancement of Blood & Biotherapies (AABB) has published a special supplemental issue of its...
Thermo Fisher Scientific has launched the Thermo Scientific™ Nicolet™ RaptIR™ X FTIR Microscope, expan...
Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agre...
NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
China Medical System Holdings has announced that its subsidiary Dermavon Holdings has received approval from China&rsquo...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...
Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mits...
What are Caidya’s major highlights for 2026 that will strengthen its presence in the global CRO market? And what a...
US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority share...
Artificial intelligence is increasingly being applied across early-stage drug discovery, but translating computational p...
Drug delivery technologies have become increasingly important as pharmaceutical developers work with complex molecules, ...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
